PBS’s Award-Winning Travelscope Host Invites Readers to Savor Life’s Journey
Los Angeles, CA, Dec. 1, 2020 ― Joseph Rosendo’s boundless globe-trotting adventures bring viewers breathtaking vistas, astonishing wildlife encounters and unforgettable cultural experiences with local inhabitants on the Emmy-winning PBS series, Joseph Rosendo’s Travelscope. Through Joseph’s insatiable passion for exploration and discovery, we all gain a taste of once-in-a-lifetime experiences and learn the value of opening our minds and senses to the world around us.
And now, he’s assembled a written collection of his favorite expeditions and added new reflections and insights in his latest book, Musings – The Short Happy Pursuit of Pleasure and Other Journeys.
Written in a conversational tone that captures his heart and soul and reveals his deep connection to the travel experience — especially as a path to pleasure, enlightenment and cultural connections — Musings is acollection of informative, entertaining and inspirational stories about travel and life’s other enjoyable pursuits for which we all yearn. It is a touching and often-humorous journey through a life propelled by a passionate and compassionate view of our world.
The stories cover decades of Joseph’s enlightening travel observations, plus a lifetime of reflections related to his personal journey. Some of the “musings,” particularly the early ones, are directly tied to travel, offering how-to tips on bargaining, packing, planning and other nuts-and-bolts travel topics. Other stories are less solidly connected to travel as an activity, and explore topics such as Joseph’s childhood adventures, his year of spring, his Cuban grandparents, his quest for the holy platter, his brunch-conquering brother and other happenings. These musings describe Joseph’s personal journey, touching on many topics, but the voyage, the passage, is always the subtext.
And it's through his belief — that it’s the journey, not the final destination, that matters most — where Joseph reveals his secrets for happy travels and a happy life: “We should keep our sense of humor and be as adaptable as possible,” he says. "And we should never, ever isolate ourselves from the experience and just observe — sightsee — from a place apart," he adds. Instead, Joseph wishes that his stories will inspire readers to commit to what’s happening in the moment and relish the good, the bad and the ugly of it. “May you live all the days of your life,” author Jonathan Swift once said. “And may you savor the journey along the way,” Joseph adds.
Travel connoisseur, motivational speaker and four-time Emmy award-winning director and host Joseph Rosendo has been a travel journalist and broadcaster since 1980. Since 2007, he has hosted, directed and written Joseph Rosendo’s Travelscope, the award-winning PBS travel television series. Joseph has been published worldwide and is the Consulting Editor for DK Eyewitness Travel Guides’ Where To Go When and Where To Go When – the Americas, as well as the author of an Insider’s Guide to Los Angeles.
To learn more, please visit www.travelscope.net or connect with Joseph on Facebook: travelscope and josephrosendostravelscope; Instagram: @josephrosendo; and Twitter: @josephrosendo.
Musings – The Short Happy Pursuit of Pleasure and Other Journeys
The Gift of Time: Care consultancy creates Advent Calendar to help caregivers make a difference this December
A leading care and culture consultancy has launched an online advent calendar to help caregivers ‘open a window of possibility’ this December – following a challenging year for the sector.
Created to help boost morale following an exhausting year spent protecting the vulnerable from the coronavirus pandemic, Meaningful Care Matters’ Gift of Time advent calendar offers ways to take a moment and make a difference each day in December - and is free for all care providers and individuals to access.
Behind each closed door is a short, simple activity to partake in with those being cared for, with the aim of helping to brighten someone’s day and make a real difference to their life. It could be anything from setting up a video call with family members, listening and dancing to someone’s favourite song with them, or sharing and reminiscing over meaningful photographs.
Explaining the reason behind the Gift of Time, Peter Bewert, Managing Director of Meaningful Care Matters, said: “When talking to many of our partners undertaking Butterfly Projects in Canada, UK and Ireland about the future, they explained it was hard to focus on the bigger parts of culture change with all that continues to go on with responding to the pandemic, staff shortages and people generally feeling exhausted.
“They said they needed something simple and achievable to help raise their team’s morale. This is how we came up with the idea of the advent calendar – things to do each day in December which focus on being kind, having fun, sharing memories and looking after each other.”
Part of Meaningful Care Matters’ new Meaningful Connections Community, a comprehensive online platform offering individuals and care providers an opportunity to share, collaborate and debate issues impacting person-centred care cultures, the calendar offers a simple way to spend quality time, kindness, and meaningful moments to those needing care this Christmas.
The first of its kind, the new platform has been designed to enable global networking through the sharing of ideas, information and experiences, as the industry the world over continues to deal with delivering care in the ‘new normal’. Those wanting to benefit from the platform’s wide range of tools and support can currently enjoy a 15 per cent discount by using the code Welcome2020 when signing up, until 31st December.
Peter concluded: “Please join us each day in opening a new window of possibility to change a moment and make a difference. Sometimes the gift of time is the most precious thing we can give. This might be for someone you support or one of your team members, or it could be for YOU, as you matter too!”
To sign up for free and find out what is behind the first door of the advent calendar, click here. Participants are also encouraged to share their daily activities across social channels using #MakeCareMeangingful #GiftofTime.
Bausch + Lomb Announces Additional Expanded Public Coverage for (Pr)VYZULTA® (Latanoprostene Bunod Ophthalmic Solution 0.024% w/w) in Canada
PrVYZULTA® Added Under British Columbia, North West Territories, the Yukon and Veteran Affairs Plans
LAVAL, QC, Dec. 1, 2020 /CNW/ - Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC), announced that PrVYZULTA® (latanoprostene bunod ophthalmic solution, 0.024% w/w), which is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertensioni, now has expanded public drug program reimbursement in Canada in the jurisdictions of British Columbia, North West Territories, the Yukon and Veteran Affairs.
These provinces join Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador and the federal Non-Insured Health Benefits (NIHB) program which made VYZULTA available to patients at various points from December 2019 to December 2020. PEI is in the final stages of their review process, while Quebec is the last remaining province to seek to increase access for Vyzulta for its patient population. Affecting over 400,000 Canadians, glaucoma is a disease of the optic nerve and the leading cause of blindness in North America.ii
"We are pleased that VYZULTA, a new treatment option that can help patients manage the potentially life-altering condition of glaucoma and possibly preserve eyesight has been recognized by most Canadian provinces and the federal government are increasing access to VYZULTA for the benefit of patients and the health care system," said Richard Lajoie, president and general manager, Bausch Health, Canada. "Bausch + Lomb is proud to continue to live its mission to help Canadians live better by enabling them to see better with our health care products."
VYZULTA has a dual mechanism of action for lowering intraocular pressure by increasing outflow of aqueous humor through both uveoscleral and trabecular meshwork routes.i VYZULTAis to be administered once daily.
"VYZULTA is the first prostaglandin analog with a Nitric Oxide (NO) releasing metabolite and reduces IOP by increasing outflow through both the trabecular meshwork and the uveoscleral pathways," said Dr. Steven Schendel, (MD, FRCSC). "I am pleased to have this innovative therapy for treatment of open angle glaucoma or ocular hypertension, which is now accessible to patients on public drug plans in British Columbia."
For Canadians, glaucoma is one of the leading causes of irreversible blindness.iii Glaucoma is defined as a group of eye diseases that slowly and progressively affect the optic nerve,v which can lead to irreversible vision loss. Open-angle glaucoma is the most common form of the disease and is associated with elevated pressure caused by a backup of fluid in the eye.iv
"For patients to have advanced standard of care for glaucoma, they need to have access to innovative treatments such as VYZULTA on public formularies," said Doug Earle, president & CEO, Fighting Blindness Canada. "Governments of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Newfoundland and Labrador, the North West Territories, the Yukon and the federal government, through the Non-Insured Health Benefits and Veteran Affairs programs are showing their commitment to glaucoma patients by making Vyzulta available to patients on public formularies. On behalf of the constituents of Fighting Blindness Canada, I am heartened to see that most provinces and jurisdictions are supporting people living with open-angle glaucoma and now have access to another treatment option that they can discuss with their optometrist or ophthalmologist."
VYZULTA received its Notice of Compliance (NOC) from Health Canada on Dec. 27, 2018 and is currently covered by most private insurance plans in Canada.
About Bausch + Lomb Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in approximately 100 countries. For more information, visit Bausch.ca.
About Bausch Health Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.
In Canada, our areas of focus include eye health, dermatology and cardio metabolic. More information can be found at BauschHealth.ca.
_______________________
i
PrVyzulta® Product Monograph, dated December 27, 2018.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology. 2006;90(3):262v Horton JC. Disorders of the Eye. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, eds. Harrison's Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill Education; 2015.
iv
Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee; Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44 Suppl 1:S7-S93.
SOURCE Bausch + Lomb Canada
ISOLOGIC acquires diagnostic FDG distribution from CPDC
Acquisition will provide hospitals, physicians and patients with a more robust and reliable supply chain for critical diagnostic FDG molecules
MONTREAL, Dec. 1, 2020 /CNW/ - ISOLOGIC Innovative Radiopharmaceuticals is pleased to announce it has reached a preliminary agreement with the Centre for Probe Development and Commercialization (CPDC) to acquire CPDC's commercial distribution of diagnostic FDG molecules. Through this agreement, ISOLOGIC will integrate 18FDG manufacturing and distribution under a single brand, while maintaining the highest level of product quality and customer service.
ISOLOGIC is committed to ensuring Canadians can depend on a reliable, efficient, and locally made radiopharmaceutical supply. Radiopharmaceuticals are used in imaging technologies, notably single photon emission computed tomography (SPECT) and positron emission tomography (PET), to diagnose and assess cancer tumors and metastases, seizures, strokes, infections and other serious medical conditions.
The vision behind this transaction is simple: to help provide improved healthcare across Canada and assist physicians by delivering the most clinically relevant PET and SPECT radiopharmaceuticals in a safe, reliable manner to ultimately help save patient's lives.
"Today's acquisition and resulting consolidation is essential to safeguarding Canada's critical radiopharmaceutical supply chain and will further improve the delivery of care to patients," said Andre Gagnon, President of ISOLOGIC Innovative Radiopharmaceuticals. "Isologic is more committed than ever to our role as a vital partner to the health system amidst the current health crisis and challenges Canada is facing."
This acquisition builds on ISOLOGIC's previous investments and strengthens its ability to meet the needs of Canadians for these critical radiopharmaceuticals safely, efficiently, and consistently. Today's announcement marks a key step in fulfilling this goal.
As a result of this acquisition, both ISOLOGIC and CPDC will be able to focus on their key strengths in serving Canada's healthcare community.
"CPDC is confident that ISOLOGIC will continue to provide excellence in service and supply for our hospital partners and their patients across Canada," said Bruno Paquin, Interim Chief Executive Officer of CPDC. "We're excited to continue expanding our ground-breaking work to discover, develop and distribute next generation imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases."
Given the short shelf-life of FDG products, the need to manufacture to rigorous Canadian GMP standards, and the essential nature of FDG-based imaging technology for Canada's health care system, this transaction will help ensure production capacity stays close to major Canadian delivery-of-care locations.
Hospitals, physicians and patients will benefit from a more robust and reliable supply chain to meet today's and tomorrow's needs. True to its track-record, ISOLOGIC will remain a strategic partner for health care systems across Canada.
"We look forward to servicing CPDC's trusted customers, and we commit to doing so in accordance with the highest national and professional standards," said Mr. Gagnon. "This acquisition will allow ISOLOGIC to maintain and enhance the level of service that CPDC's customers have experienced in the past. Our objective is to build on these important relationships and to grow new, long-lasting ones."
About ISOLOGIC Innovative Radiopharmaceuticals Inc.
ISOLOGIC Innovative Radiopharmaceuticals (ISOLOGIC) is a Canadian company dedicated to nuclear medicine and the science of radiopharmaceutical production. ISOLOGIC's commitment in these areas includes cyclotron centers, SPECT and PET radiopharmaceutical manufacturing facilities across Canada. We use our increased experience, expertise and radiopharmaceutical network to provide our customers and patients reliable, safe and high-quality radiopharmaceutical products and services. ISOLOGIC's radiopharmaceutical drug and medical device offers flexibility of choice, providing its clients with access to all radiopharmaceuticals that have Health Canada's market authorization.
SOURCE IsoLogic Innovative Radiopharmaceuticals
Alcon Canada to launch a professional line of Systane Ultra HYDRATION Lubricant Eye Drops Preservative Free
Featuring a preservative-free formula with Hyaluronic Acid (HA) and HP-Guar, which:
Provides 2X greater cell hydration and protection vs. HA alone.*1
Significantly improves the rate of corneal healing and restoration of damaged cells vs. HA alone.**2
Is recommended for patients with moderate or chronic dry eye disease or suffering from post-surgery dryness who want long-lasting relief.3,4
Is in multi-dose bottle and scheduled to launch December 1, 2020, in Canada, at select Eye Care Professional practices.
MISSISSAUGA, ON, Dec. 1, 2020 /CNW/ - Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the Canadian launch of the newest addition to its innovative portfolio of dry eye products – a professional line of SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free. These new eye drops contain both Hyaluronic Acid (HA) and HP-Guar, a powerful combination of ingredients shown to offer long-lasting dry eye relief for those suffering from moderate or chronic dry eye. Patients suffering from dry eye symptoms after LASIK or cataract surgery can also benefit.4 The dual-polymer formula provides 2X greater cell hydration and protection vs. hyaluronic acid (HA) alone*1.
"At Alcon, we know the importance of meeting the needs of consumers who are frustrated by chronic dry eye problems. Today, we're expanding our portfolio of products with the addition of SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free," said Chris Van Dyk, Country Business Head, Alcon Vision Care. "There are patients who are constantly afflicted by dry eye; it can distract them from morning to night and significantly impact their daily activities. Now, these sufferers can get long-lasting relief that allows them to focus on their lives, not their dry eye."
SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free will launch with patented PureFlow® Technology, a multi-dose closing tip bottle system that features a one-way valve to ensure that no contaminated liquid is re-introduced into the container after a drop has been dispensed. This bottle technology eliminates the need for preservatives in the eye drops.
Since 2004, Systane® has been tested in more than 50 clinical studies, which provides eye care professionals the confidence of knowing they are recommending a family of clinically proven formulas.5 Moreover, patients will enjoy both ease of use and long-lasting, preservative-free symptom relief.4 SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free are also safe for use rewetting all silicone hydrogel and soft contact lenses.6
"SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free have become my preferred choice to promote corneal healing and help to significantly improve symptoms in my dry eye patients,2,4" said Judy Parks, O.D. at the Ancaster Eye Clinic. "With the clinically proven dual-polymer formula of Hyaluronic Acid (HA) plus HP-Guar in a preservative-free formulation, more of my patients can enjoy powerful protection and relief.4"
The commercial availability of SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free begins December 1, 2020. This product will be available in select Professional Eye Care clinics.
Important Information for the Systane Family of Products
Systane® Ultra HYDRATION Lubricant Eye Drops Preservative Free have been clinically proven to reduce the symptoms of dry eye, providing, long-lasting protection and comfort.4 Both SystaneTM Ultra HYDRATION Lubricant Eye Drops Preservative Free and Systane® Ultra HYDRATION Lubricant Eye Drops give long-lasting relief of dry eye symptoms for moderate or chronic sufferers, as well as patients who are suffering from dry eye symptoms after cornea surgery.4 SystaneTM COMPLETE is an all-in-one formula that is clinically shown to provide instant and 8-hour relief for all types of dry eye.10 Systane® GEL DROPS are indicated for patients who suffer from severe dry eye and need night-time relief from their symptoms.7
Systane® LID WIPES provides complementary care for everyday eyelid hygiene with pre-moistened wipes for easy, on-the-go application. SYSTANE® OMEGA-3 SUPPLEMENTS help support proper tear function in persons with dry eye disesase8,9
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products that improve people's lives by helping them to see better. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.ca. You can also connect with us on Instagram and Facebook.
*In vitro study **Study conducted in mice
_____________________________
1.
Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.
2.
Ogundele A, Kao W, Carlson E. Impact of Hyaluronic Acid Containing Artificial Tear Products on Re-epithelialization in an In Vivo Corneal Wound Model. Poster presented at: 8th International Conference on the Tear Film & Ocular Surface; September 7-10, 2016; Montpellier, France.
3.
Davidson R, Schultz-Scott B. Efficacy Evaluation of SYSTANE® ULTRA in Patients with dry Eye Undergoing Cataract Surgery. Poster Presented at: 30th Congress of the European Society of Cataract and Refractive Surgeons: September 8-12, 2012, Milan, Italy
4.
Mrukwa-Kominek E, Baranska K, Jadczyk K. First clinical reports on the application of the modern dual-polymer formula in aqueius deficiency dry eye syndrome: Polish observations. Poster presented at: 20th European Society of Cataract & Refractive Surgeons Winter Meeting; February 26-28, 2016; Athens, Greece
5.
Based on clinical trials analysis for Systane vs. competition using information sources from clinicaltrials.gov; Alcon data on file, 2019.
6.
Alcon data on file, 2014.
7.
Christensen M, Martin A, Meadows D. An evaluation of the efficacy and patient acceptance of a new lubricant eye gel. The American Academy of Optometry Annual Meeting; 2011; E-Abstract 115013.
8.
Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: A review. Cont Lens Anterior Eye. 2010;33(2):49-54.
9.
Giannaccare et al. E.cacy of Omega-3 Fatty Acid Supplementation for Treatment of dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials. Cornea. 2019 May;38(5):565-573.
10.
Guillon M, Patel K, Gupta R, Srinivasan S. Sustained symptom relief following a single dose of PG/HPG-nanoemulsion in patients with dry eye disease. Poster presented the American Academy of Optometry Annual Meeting. October 23-26, 2019, Orlando FL.
SOURCE Alcon Canada
Duracell® Debuts Breakthrough Child Safety Feature for Lithium Coin Batteries, Offering a New Advancement in Safety to Help Discourage Swallowing
As holiday season approaches Canadians are provided the ability to "Power Safely"
TORONTO, Dec. 1, 2020 /CNW/ - Duracell, the most trusted battery brand, launches its latest innovation in child safety, a bitter coating on its lithium coin batteries -- sizes 2032, 2025, and 2016. This breakthrough innovation in the battery category is designed to help discourage swallowing. With coin battery ingestions on the rise annually and damage that can occur in just two hours from ingestion, Duracell was determined to provide parents and caregivers of young children with an additional safety feature, child-safe packaging, and supportive education to help reverse this rising and devastating trend.
Duracell Lithium Coin batteries (sizes 2032, 2025, and 2016) will now contain a non-toxic, bitter coating designed to help discourage swallowing. This bitter coating is applied to these battery sizes which have a diametre of 20mm, which is similar to the size of a child's esophagus. If a child swallows a lithium coin battery, it can get lodged in the esophagus and burn through the surrounding tissue in as little as two hours, causing serious damage.
"Having treated young children in the emergency room who have accidentally swallowed lithium coin batteries, I have experienced firsthand the detrimental physical impact to these children and effects on the parents," says Dr. Dina Kulik, pediatrician and emergency medicine physician. "As a mother of four young boys myself, I can appreciate how important it is for parents to be aware of this serious issue and making sure the appropriate precautions are taken to help protect our children."
For additional safety, Duracell's Child Secure Pack features a tough double blister around the lithium coin cell that is nearly impossible to open without scissors. Duracell is also providing supportive education through its "Power Safely" initiative, which aims to educate consumers on the potential hidden dangers in the home, steps to take to decrease accidental ingestions and further child safety measures they can adopt.
"Duracell takes very seriously the trust that millions of consumers across North America place in us to power their lives every day. And our new bitter coating innovation is an important step in child safety for us as a brand. We are proud to work with our retailer partners and other stakeholders in bringing this innovation to market," says Roberto Mendez, President, Duracell North America. "If a child manages to get access to a lithium coin cell and swallows it, consequences can become serious if not detected fast enough. In order to help prevent accidents and help keep children safe, we've worked to provide more child safety features around our lithium coin cells than other leading brands. This new innovation is no different, and we are confident this is the technology families and caregivers need to help close the gap between a child getting their hands on a lithium coin cell and the unfortunate event of ingestion."
Lithium coin batteries are commonly used in a number of devices throughout the home such as remote controls, calculators and bathroom weight scales. During the holiday season there are likely more objects in the home powered with this type of battery such as string lights, holiday ornaments, greeting cards with sound, as well as certain toys and games and other electronics that may be given as gifts. The Duracell lithium coin battery with its added safety features can more safely power these common devices delivering peace of mind to parents and caregivers.
According to Kulik, young children are naturally curious and eager to explore their environment. With children spending more time at home, particularly over the holidays, parents should be mindful of potential safety risks. She adds, "Parents should regularly inspect and secure battery-operated devices around the home and keep batteries safely out of reach. When required, using lithium coin batteries designed with child safety in mind, parents can provide an extra layer of protection."
While this technology is revolutionary in the battery category, Duracell also believes battery safety education is critical to truly change the outcome for families around accidental ingestion. That is why Duracell is embarking on the Power Safely initiative to help educate parents and caregivers as to the importance of practicing battery safety throughout the home.
To kickstart the Power Safely campaign, Duracell has created an informational educational video to shed light on the effects lithium coin battery ingestions can have on young children and to help encourage better practices and prevention among parents and caregivers. The video showcases how even the most child-proofed home can still have hidden dangers that may be inadvertently overlooked, and how important the extra line of defense from the new non-toxic bitter coating may be to help protect children from the dangers of accidental ingestion.
Duracell lithium coin batteries in 2032, 2025, and 2016 sizes are available now at select retailers nationwide. The suggested retail price for a 4-pack of Duracell Lithium Coin batteries is $15.99.
For more safety tips and to learn more about Duracell's new lithium coin battery, please visit Duracell.com or visit @Duracell on Facebook.
About Duracell
Started in the 1920s, the Duracell brand and company was acquired by Berkshire Hathaway Inc. (NYSE-BRK.A, BRK.B) in 2016 and has grown to be the leader in the primary battery market in North America. The iconic Duracell brand is known the world over. Our products serve as the heart of devices that keep people connected, protect their families, entertain them, and simplify their increasingly mobile lifestyles. Our recharging technology allows consumers to live life without limits. Berkshire Hathaway Inc. is a $250B holding company owning subsidiaries that engage in diverse business activities. Visit www.duracell.com for more information; follow us on Twitter.com/Duracell and like us on Facebook.com/Duracell.
SOURCE Duracell
STRETCHING & THE SOUL: THE KEY TO HEALTH IN 2021?
Orthopedic Surgeon Shares Why Stretching & Mindfulness Are More Crucial Than Ever in the Sedentary COVID EraRemember the expression “sitting is the new smoking”? This phenomenon still rings true and it has gotten worse because of COVID-19. One of the many negative effects of the pandemic is that it has made Americans even more sedentary - and the effects of this are long lasting. With the continued rising number of Coronavirus cases, more people are staying home, working remotely, and getting less exercise, and simply not moving enough.
According to Orthopedic Surgeon Dr. Zvi Pearlstein, the COVID-imposed sedentary lifestyle poses more health risks than you would think."Before the pandemic, America was in the midst of another health crisis: physical inactivity and sedentary behavior. While it may seem minor in comparison, according to the WHO, 3.2 million deaths per year are attributed to this unhealthy lifestyle behavior..."
...says Dr. Zvi, who, as an Orthopedic Surgeon has seen the negative health consequences of ubiquitous sedentary lifestyle on muscle and joint function. It causes a limitation of motion and function, and a continued weakening of the body. Not only does this exacerbate musculoskeletal pain, it is the base of much human ill-being and can cause a myriad of other health issues including obesity, low back pain, heart disease, high blood pressure, depression, anxiety, and cancer.
So we should all go for a run, do some cardio, and get our blood pumping, right? Yes of course...but that's not enough, according to Dr. Zvi.
“Just as important as aerobic activity is stretching and mindfulness. They are more crucial than ever in the sedentary COVID era and they need to be an integral part of your workout plan for 2021...”
...says Dr. Zvi, who is an advocate of health wisdom and non-invasive care to reduce pain and improve overall health and wellbeing. A pioneer in holistic wellness and pain management, he stresses the importance of healthy movement along with other alternative solutions - philosophies that are disrupting the status quo of therapy. Dr. Zvi developed the alternative solutions comprising his “Pain Toolbox” to help transform healthcare from the information age to the wisdom age. Through his video tutorials including the 1 Minute Stretch™ and Stretching for Pain Relief Video Series, and his newSitFit Chair™(a total body gym in an innovative non-sedentary, multi-positional, and multi-functional chair), he is able to connect with patients and provide simple and straightforward solutions to optimize health, wholeness, and happiness through the unique concept of "Soul & Body".Dr. Zvi is sharing insight and actionable advice to optimize health during the COVID holidays and New Year. He has tips people can use to include stretching and mindfulness into their workout and why it is crucial for health in 2021.TALKING POINTS (FOR INTERVIEWS & ARTICLES):Insight & Actionable Advice to Optimize Health During the COVID Holidays & New Year.Why Stretching & Mindfulness Need to be Part of Your Health Plan for 2021 (& How You Can Do It)Expert Tips To Combat Sedentary COVID Lifestyle The Negative Health Consequences of the COVID Sedentary Lifestyle on Our BodiesEasy Tips & Alternative Solutions to Optimize Health, Wholeness, & HappinessThe Fascinating Link Between Mental Health & Physical PainIs Sitting REALLY the New Smoking?The Pain Management ToolboxWhat is Missing From the Diet/Wellness Industry? ABOUT DR. ZVI:Dr. Zvi Pearlstein is a Doctor, Father, Speaker, Author, Inventor... And Trumpeter. From a young age, Dr. Zvi had a deep-seated need and calling to find life’s meaning and purpose to understand and solve pain. His mother Celia passed in 2019 leaving behind writings and poetry of her emotional experiences during the Holocaust in Poland. In 1976 Dr. Zvi received his BA in Biochemistry from Princeton University. In 1981 he received his MD from New York University School of Medicine. He completed a 5-year residency in Orthopedic Surgery at SUNY Downstate in Brooklyn in 1986. As a Major in the United States Air Force, Dr Zvi spent three years practicing orthopedic surgery at Clark Air Base in the Philippines and one year at Andrews Air Force Base in Wash. DC. He did active duty service during Persian Gulf War I. While serving in the Air Force he was a marksman shooter and was awarded the Sikorsky Helicopter Rescue Award. Throughout his career he was looking for truth and often felt that certain problems needed better wellness and lifestyle answers and solutions. As a result, over the past 30 years he developed a series of products, inventions, books, and services, which he now sets in motion with his company Missing Links Health, Inc.For More Information Visit: https://www.drzvi.com
Drake’s Organic® Spirits Boxtails™
Coming to Cub Wine & Spirits
Newest product from Minneapolis-based Drake’s offers
ready-to-drink craft cocktails on tap
Minneapolis, MN (December 1, 2020) -Drake’s Organic Spirits announced today that Boxtails™, the company’s innovative new ready-to-drink (RTD) pre-mixed organic craft cocktails in a box, will be available at all 27 Cub Wine & Spiritslocations in Minnesota beginning December 4th, 2020. Boxtails fill the surging demand for spirit-based RTDs, a cocktail category that has seen explosive growth of over 80% in 2020.
Drake’s OrganicBoxtails are made with Drake’s signature ultra-premium organic certified vodka and rum. Offered in Watermelon Tini, Mango Punch, Black cherry Limeade and Minted Mojito flavors, Boxtails provide a convenient alternative to canned seltzers and with less waste. Each box contains 1.75 liters of pre-mixed organic cocktails with 12% alcohol similar to a standard mixed cocktail. The estimated retail price is $19.99.
“We are very pleased to offer our USDA Organic Boxtails to customers of Cub Wine & Spirits,” said Mark Anderson, founder and CEO of Drake’s Organic Spirits. “Like Drake’s, Cub is a respected homegrown Minnesota company. They’ve been delivering great value and supporting the community for over 50 years. Today’s announcement extends the reach of the Drake’s brand and ensures adult consumers in our home state can conveniently purchase our better-for-you, better-for-the-planet spirits.”
All Drake’s products including Boxtails are USDA Organic, Non-GMO Project Verified, gluten-free, vegan and kosher. They contain no artifical flavors, colors or unnecessary chemicals. Ingredients are sourced from the world’s most pristine organic fields.
About Drake’s Organic Spirits Launched in 2017, Minneapolis-based Drake’s Organic Spirits is the first and only spirits line in the world Certified USDA Organic, Gluten Free™, Non-GMO Project Verified, vegan and kosher. Drake’s uses the highest quality USDA Organic and non-GMO Project Verified ingredients to create a line of ultra-premium,12x distilled spirits and mixes at a better price than the leading premium brands.
Drake’s OrganicPremium Vodka was awarded Double Gold and Drake’s Organic White Rum received Gold at the most recent Wine & Spirits Wholesalers of America (WSWA) Convention & Exposition in Orlando, FL. The highly-respected awards are widely considered among the most prestigious in the industry because judges are industry experts who blind taste-test each spirit.
Helmet Based Ventilation Named Finalist for WomenTech Global Awards 2020
The Helmet-based ventilation initiative has been recognized as one of the best women-led tech startups of the year. All of the finalists will be celebrated in the upcoming award ceremony hosted by the WomenTech Network, along with 100000 women, minorities, and allies in tech
December 1st, 2020. Helmet-based technology has been nominated among the most promising startups by the WomenTech Network – the world's largest community for women in tech, representing 161 countries and over 4,300 ambassadors worldwide.
Since the start of the pandemic, acquiring ventilators and having enough sedatives, as well as qualified clinicians, to operate them, has been a greatchallenge for the medical community worldwide. Seeking to alleviate the shortage, as well as provide the professionals with a better way to treat patients with acute respiratory failure—a prevalent symptom in severe COVID-19 cases—inspired a team of experts to launch awebsite introducing helmet-based ventilation (HBV) technology.
“Our goal was to share our niche expertise in the field and help healthcare professionals fighting in the frontlines to contain the pandemic,” said Aurika Savickaitė, MSN, RN, and team leader behind the initiative.
The helmet-based ventilation therapy is non-invasive, which results in less stress for the patient and shortens the recovery time. In some cases, they can help avoid intubation, which often leads to life-long damage, thus limiting risks for the patient. Compared to a typical ventilator, helmets are more cost-efficient to produce and can be made in underdeveloped countries. That said, they also have to be used in hospital settings by the clinicians.
Spreading awareness, gathering resources for new manufacturers, and other hard work paid off: recently the "subsalve" oxygen treatment hood gained FDA EUAapproval. The HBV team continues to consult local, as well as experts fromaround the world, to help them build the so-called “bubble helmets” themselves at local facilities and equip their home market with the in-demand non-invasive ventilators, needed to treat most severe cases of COVID-19.
The success of the HBV initiative earned it the finalist spot in the “Women-led Startup of the Year 2020”. The winners will be announced on December 3rd, at theWomenTech Global Awards 2020, featuring 2238 contestants from 153 countries in 22 categories.
“We are incredibly thrilled to be nominated alongside other great projects that inspire not only ingenuity but also incredible perseverance to pursue set goals and overcome adversity,” said Aurika Savickaite. “Without a doubt, this is also a huge incentive for us to keep on spreading the word about helmet-based ventilation, uniting experts from all around the world and refining the technology further.”
The Womentech Global Awards 2020 is a natural continuation of the WomenTech Global Conference 2020, the largest virtual conference for women in tech. Back in March, when the world was going into the first lockdowns due to COVID-19, Anna Radulovski, founder and CEO of WomenTech, together with her team came up with an idea that would unite women entrepreneurs amidst the unprecedented circumstances.
“After the WomenTech Global Conference 2020, we received tons of positive feedback, many sharing about their hardships with uncertainty, job security and work-life-balance while working remotely and how the community inspired them to overcome them,” Anna Radulovski said.
“We understand the importance of celebrating small and big successes while adapting to a life in a digital-first world. This is why we want to give visibility and recognition to accomplished and aspiring female tech leaders as well as allies, working toward a more equal and inclusive world.”
People interested in attending one of the largest award ceremonies for women in tech can apply for an invite or get tickets for themselves or on behalf of the company they work for via theWomenTech website. More details on the event, as well as any updates, can be found athttps://www.womentech.net.
-END-
ABOUT HELMET-BASED VENTILATION INITIATIVE
Helmet-based ventilation initiative was born as a private endeavor of experts and professionals in the field, most of them based in Chicago. The initiative strives to curate, consolidate and share the most niche and up-to-date information about helmet-based ventilation, while connecting professionals in need of this know-how | www.helmetbasedventilation.com
WomenTech Network is the world's largest community for women in tech with more than 4300 ambassadors representing 161 countries. Since 2018 its founders have engaged +141,000 tech specialists to join in building a diverse global community inspiring and reaching +1 million people in 2020 alone. The Network strives to increase gender diversity in the workplace to improve equality across all areas like representation, promotion and equal pay.
The Network’s mission is to empower communities of talented and motivated women in tech through leadership development, professional growth, mentorship, and networking events to make a difference by building impactful and inclusive technology, while introducing them to like minded people, inspiring speakers and opportunities at leading companies and innovative startups that aim to create diverse teams and a culture of belonging. More information: https://www.womentech.net/
HumanisRx signs agreement with The North West Company to provide Proactive Medication Optimization
MARKHAM, ON, Dec. 1, 2020 /CNW/ - HumanisRx today announced it has entered into an agreement to provide medication optimization services to The North West Company (TSX: NWC) by leveraging its MedMonitor program. MedMonitor is a unique Canadian program applying RxCompanion™ software to run clinical algorithms against prescription data to identify risks related to a patient's medication therapy. Patients who are provided health and pharmacy services by NWC will be referred directly to the MedMonitor program.
NWC provides high quality and vital healthcare services in remote locations in a large geographical region in Northern Canada. The distance these patients must travel for healthcare makes monitoring and follow-up for disease management difficult, leading to a pressing need for improved primary care in remote northern communities. Utilizing MedMonitor, NWC aims to identify patients with more urgent need of healthcare services to address their issues earlier before their conditions escalate and require more severe and costly intervention.
Earlier this year, NWC engaged HumanisRx to conduct a study on 9,000 of its patients using RxCompanion™ software. The study found:
One in every 2.5 patients had at least one drug therapy problem.
Drug therapy problems related to mental health were identified most often followed by diabetes and cardiovascular disease.
16% of patients had multiple drug therapy problems, carrying a higher risk of health issues leading to increased morbidity and healthcare costs.
"We are very excited to have partnered with HumanisRx in an effort to further enhance patient care utilizing their population-level monitoring tool that identifies patients at risk of poor health outcomes." states Laurie Kaminsky, Vice President, Health Product & Services, North West Company. "Our healthcare teams of physicians and pharmacists will act on the risks identified to proactively improve the quality of health services to the remote populations we are proud to serve."
"Both public and private payors and healthcare providers can improve efficiency and realize signification cost savings through the implementation of MedMonitor," said Sayeh Radpay, President of HumanisRx. "Through earlier identification and resolution of medication-related health risks, MedMonitor helps resolve problems before they escalate and even avoid some health issues altogether."
About HumanisRx HumanisRx Corporation helps Canadians with complex or unique needs get the best results from their medications. Its team of licensed pharmacists and technology experts is dedicated to building solutions that support the shared goals of private and public payors, healthcare providers, health organizations and the Canadians they serve. RxCompanion™ is a software solution powered by Tabula Rasa HealthCare.
About The North West Company The North West Company Inc., through its subsidiaries, is a leading retailer of food and everyday products and services to rural or remote communities and urban neighbourhoods in Canada, Alaska, the South Pacific and the Caribbean. North West operates 249 stores under the trading names Northern, NorthMart, Giant Tiger, Alaska Commercial Company, Cost-U-Less and RiteWay Food Markets and has annualized sales of approximately CDN$2.0 billion.
SOURCE HumanisRx
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
"Before the pandemic, America was in the midst of another health crisis: physical inactivity and sedentary behavior. While it may seem minor in comparison, according to the WHO, 3.2 million deaths per year are attributed to this unhealthy lifestyle behavior..."
Dr. Zvi Pearlstein is a Doctor, Father, Speaker, Author, Inventor... And Trumpeter. From a young age, Dr. Zvi had a deep-seated need and calling to find life’s meaning and purpose to understand and solve pain. His mother Celia passed in 2019 leaving behind writings and poetry of her emotional experiences during the Holocaust in Poland. In 1976 Dr. Zvi received his BA in Biochemistry from Princeton University. In 1981 he received his MD from New York University School of Medicine. He completed a 5-year residency in Orthopedic Surgery at SUNY Downstate in Brooklyn in 1986. As a Major in the United States Air Force, Dr Zvi spent three years practicing orthopedic surgery at Clark Air Base in the Philippines and one year at Andrews Air Force Base in Wash. DC. He did active duty service during Persian Gulf War I. While serving in the Air Force he was a marksman shooter and was awarded the Sikorsky Helicopter Rescue Award. Throughout his career he was looking for truth and often felt that certain problems needed better wellness and lifestyle answers and solutions. As a result, over the past 30 years he developed a series of products, inventions, books, and services, which he now sets in motion with his company Missing Links Health, Inc.For More Information Visit: 
